This Week’s Life Science Headlines

December 1, 2013
/
Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Product Liability Recalls Regulatory Settlements
/

Life Science Matters

Litigation

Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide
Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required)
Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required)
Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine
Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required)
OxyElite Pro Class Action Filed Over False Advertising
First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014
J&J Takes Innovative,

…
Continue reading...

This Week’s Life Science Headlines

November 15, 2013
/
Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Preemption Recalls Regulatory Settlements Supplements
/

Life Science Matters

Litigation

Eli Lilly, Others Urge 6^th Circ. To Toss Darvocet Appeal (subscription required)
McNeil Asks Pa. Appeals Court to Boot $10M Motrin Verdict (subscription required)
J&J to Pay $4B to Settle Hip Implant Suits (subscription required)
J&J Trying to Back Out of 77 Risperdal Deals, Plaintiffs Say (subscription required)
Birth Defect Lawyers in Effexor MDL Assigned to Leadership Roles
Final Bard Avaulta Vaginal Mesh Bellweather Trial Set for Dec. 3
Stryker Rejuvenate Hip Attorneys Assigned to leadership Positions in MDL

…
Continue reading...